Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia

[Image: see text]Shunt occlusion prior to lenvatinib administration prevented hyperammonemia and hepatic encephalopathy. Shunt occlusion may be an effective treatment option to administer molecular target agents in patients with portosystemic shunts.

Detalles Bibliográficos
Autores principales: Kuwahara, Ai, Sasaki, Ryu, Fukushima, Masanori, Haraguchi, Masafumi, Miuma, Satoshi, Miyaaki, Hisamitsu, Nakao, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411641/
https://www.ncbi.nlm.nih.gov/pubmed/32782972
http://dx.doi.org/10.1002/jgh3.12351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411641/
https://www.ncbi.nlm.nih.gov/pubmed/32782972
http://dx.doi.org/10.1002/jgh3.12351

Ejemplares similares